Background: Echocardiography is the method of choice to detect left ventricular systolic dysfunction (LVSD), but access to this examination is limited. Therefore, simpler diagnostic tests would be of clinical importance. Objectives: We sought to evaluate the performance of a new N-terminal pro-brain natriuretic peptide (NT-proBNP) analysis in diagnosing LVSD in primary care patients with a provisional diagnosis of heart failure referred for echocardiography. Methods: Serum levels of NT-proBNP were measured with an immunoassay and left ventricular ejection fraction (LVEF) was assessed by echocardiography in 367 patients. Results: Mean age of the patients was 68.8 years (39.0–84.0 years), and 54% were female. Ten percent of the patients had LVEF <0.40. Depending on which cutoff values were used, NT-proBNP analysis detected patients with LVEF <0.40 with a sensitivity of 91–100% and specificity of 46–60%. If the limit for LVSD was set to 0.30, the sensitivity was 100% and the specificity ranged from 44 to 58%. The area under the receiver operating characteristics curves for detecting LVEF ≤0.30 and LVEF ≤0.40 was 0.93 and 0.87, respectively. Conclusion: Irrespective of which cut off value is used, normal NT-proBNP levels effectively rule out LVSD in primary care patients referred for echocardiographic evaluation of possible heart failure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.